21.7401.98% ( -0.440 )
Delay Closed: Nov 17, 16:08:13Valuation
Current ValuationThe current P/E ratio is 12.19, below the reasonable range, cheaper than 80.37% of the time in the past 5 years, and the industry ranks 2/15, the industry Median 12.19.
12.19xP/E
HK$21.74Stock price
HK$1.78Earnings per share
12.19xP/E
Stock priceHK$21.74Earnings per shareHK$1.78
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 19.44x
- Typical range
- 12.25x–41.83x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 12.19x
012243648
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 12.19x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
06127HKJOINN | 12.19x | 241.61% | HK$16.29B |
03880HKMedtide Inc. | 13.81x | -- | HK$2.69B |
01873HKVIVA BIOTECH | 11.95x | -- | HK$2.45B |
06118HKAUSTAR | 13.02x | -- | HK$258.85M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
